Latest Breaking News On - Arnold lippa - Page 6 : comparemela.com

NA Proactive news snapshot: Vicinity Motor Corp, Empress Royalty Corp, Tribe Property Technologies Inc, RespireRx Pharmaceuticals, One World Lithium Inc, Kidoz Inc, PyroGenesis Canada Inc, Mydecine Innovations Group Inc, Vicinity Motor Corp, Recruiter com

NA Proactive news snapshot: Vicinity Motor Corp, Empress Royalty Corp, Tribe Property Technologies Inc, RespireRx Pharmaceuticals, One World Lithium Inc, Kidoz Inc, PyroGenesis Canada Inc, Mydecine Innovations Group Inc, Vicinity Motor Corp, Recruiter com
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomBritish columbiaDepartment of energyDistrict of columbiaDel coloradoPumpkin hollowEl rinconCave creekRichmond upon thamesSanta cruzRed lakeNorth birchCity ofIron creekCerro caliche

RespireRx Pharmaceuticals Inc is developing innovative and revolutionary treatments to combat neuronal signaling disorders

Deep Dive - RespireRx Pharmaceuticals

Jodi smithJames cookJeffrey witkinRok cerneArnold lippaRespirerx pharmaceuticalsReceptor neurobiologyBiochemical pharmacologyIndianapolis jodi smith

RespireRx Files Provisional Patent for Dronabinol Tech

Expansion of dronabinol’s use into OSA and other therapeutic indications will require new, improved formulations, according to RespireRx.

Jeffrey kingArnold lippaRespirerx pharmaceuticals incPatent networks law groupPatent networks law

RespireRx Pharmaceuticals files patent for lipid-based formulation tech to develop cannabinoids

RespireRx Pharmaceuticals (OTCQB:RSPI) Inc Interim CEO Arnold Lippa tells Proactive it has filed a provisional patent application for a novel lipid-based.

Arnold lippaInc interimRespirerx pharmaceuticals

RespireRx Pharmaceuticals Inc files provisional patent application for lipid-based formulation technology to develop cannabinoids

RespireRx Pharmaceuticals (OTCQB:RSPI) Inc said it has filed a provisional patent application for a novel lipid-based formulation technology (LFT) that may.

Arnold lippaRespirerx pharmaceuticalsDrug administration as marinolDrug administration